Back
Biomarin Pharmaceutical Stock Price Chart
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
65
BMRN
Biomarin Pharmaceutical
Last Price:
$71.39
Seasonality Move:
2.18%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bullish and BMRN is experiencing slight selling pressure.
Biomarin Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.68 | Sell |
| 20-day SMA: | 71.25 | Buy |
| 50-day SMA: | 67.08 | Buy |
| 200-day SMA: | 73.66 | Sell |
| 8-day EMA: | 71.65 | Sell |
| 20-day EMA: | 70.73 | Buy |
| 50-day EMA: | 68.82 | Buy |
| 200-day EMA: | 72.57 | Sell |
Biomarin Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.19 | Buy |
| Relative Strength Index (14 RSI): | 55.89 | Buy |
| Chaikin Money Flow: | -467450 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.72 - 71.96) | Buy |
| Bollinger Bands (100): | (63.42 - 69.48) | Buy |
Biomarin Pharmaceutical Technical Analysis
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Biomarin Pharmaceutical Stock
Is Biomarin Pharmaceutical Stock a Buy?
-
Biomarin Pharmaceutical share price is 71.44 while BMRN 8-day simple moving average is 71.68, which is a Sell signal.
-
The stock price of BMRN is 71.44 while Biomarin Pharmaceutical 20-day SMA is 71.25, which makes it a Buy.
-
Biomarin Pharmaceutical 50-day simple moving average is 67.08 while BMRN share price is 71.44, making it a Buy technically.
-
BMRN stock price is 71.44 and Biomarin Pharmaceutical 200-day simple moving average is 73.66, creating a Sell signal.
BMRN Technical Analysis vs Fundamental Analysis
Buy
65
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy or a Sell?
-
Biomarin Pharmaceutical stock is rated a BuyThe current Biomarin Pharmaceutical [BMRN] share price is $71.44. The Score for BMRN is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
Biomarin Pharmaceutical Stock Info
Market Cap:
13.6B
Price in USD:
71.44
Share Volume:
1.2M
Biomarin Pharmaceutical 52-Week Range
52-Week High:
94.85
52-Week Low:
60.63
Buy
65
Biomarin Pharmaceutical (BMRN)
is a Buy
Biomarin Pharmaceutical Share Price Forecast
-
What is the Biomarin Pharmaceutical stock price today?The Biomarin Pharmaceutical stock price is 71.44 USD today.
-
Will BMRN stock go up or go down?Biomarin Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators
-
Is Biomarin Pharmaceutical overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biomarin Pharmaceutical is not overvalued.
Is Biomarin Pharmaceutical Stock a Buy?
-
Biomarin Pharmaceutical share price is 71.44 while BMRN 8-day exponential moving average is 71.65, which is a Sell signal.
-
The stock price of BMRN is 71.44 while Biomarin Pharmaceutical 20-day EMA is 70.73, which makes it a Buy.
-
Biomarin Pharmaceutical 50-day exponential moving average is 68.82 while BMRN share price is 71.44, making it a Buy technically.
-
BMRN stock price is 71.44 and Biomarin Pharmaceutical 200-day simple moving average is 72.57, creating a Sell signal.
Fundamental Analysis of Biomarin Pharmaceutical
Is Biomarin Pharmaceutical a good investment?
-
Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.13 per share, an increase this year of $1.01 per share, and an increase next year of $1.04 per share.
Technical Analysis of Biomarin Pharmaceutical
Should I short Biomarin Pharmaceutical stock?
-
BMRN Moving Average Covergence Divergence (MACD) indicator is 1.19, suggesting Biomarin Pharmaceutical is a Buy
-
Biomarin Pharmaceutical Relative Strength Index (RSI) is 55.89, which suggest Biomarin Pharmaceutical is overbought
-
The Bollinger Bands (25) for Biomarin Pharmaceutical is (69.72 - 71.96), which suggest Biomarin Pharmaceutical is a Buy
-
The Bollinger Bands (100) for Biomarin Pharmaceutical is (63.42 - 69.48), which suggest Biomarin Pharmaceutical is a Buy
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.